Cell Therapy
You are here: Home » Cell Therapy
CELL THERAPY
Non-invasive prenatal screening, detection of neonatal genetic diseases such as congenital hypothyroidism and phenylketonuria.

HCC-Positive

To determine its utility in the detection of HCC, we assessed the HCCscreen assay in the individuals who have a known diagnosis of HCC or have been excluded (non-HCC). We obtained 65 HCC cases and 70 non-HCC cases from the AFP/US-positive/suspected individuals. This HCC-positive or HCC-negative status was based on dynamic CT/MRI imaging and histologic confirmation.
 

ROI

These 135 cases were used as the training cohort, and the HCCscreen results were compared with the clinical diagnosis. To build a classifier integrating different types of biomarkers in the assay, we first collapsed the different types of cfDNA mutations into a region of interest (ROI) score for each gene or locus (see Methods). The ROI score was a weighted sum of the damaging effects and frequency for each point mutation within a ROI.
 
Founded in 2012, we produce thermal interface materials & insulation
materials, which serve diverse electronics fields. With ISO 9001/ISO14001/IATF 16949/REACH/SGS/ROHS certificate, we export products worldwide.
  +86-189-8873-5389
  +86-18988735389
  Room 101, Building A, No. 31, Shiwei Reservoir Road, Shiwei Community, Matan Street, Guangming District, Shenzhen.

QUICK LINKS

QUICK LINKS

PRODUCT CATEGORY

PRODUCT CATEGORY

Copyright © 2025 ShenZhen DuBang Technology Co., Ltd. All Rights Reserved. Sitemap
Contact Us